Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity

• Үндсэн зохиолчид: Stacey Tannenbaum (Зохиогч), Martin den Adel (Зохиогч), Walter Krauwinkel (Зохиогч), John Meijer (Зохиогч), Adriana Hollestein‐Havelaar (Зохиогч), Frank Verheggen (Зохиогч), Donald Newgreen (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Wiley, 2020-12-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract The aim of this investigation was to characterize and compare the pharmacokinetics (PK) of the antimuscarinic drug solifenacin in pediatric patients with overactive bladder (OAB) or neurogenic detrusor overactivity (NDO) utilizing data from three phase III trials. LION was a placebo‐control...